David Robinson, MD
Emergency Medicine · Houston, TXNPI 1831115922
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,375 of the $143,146 with a category attached, or 68.0%. 13 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 42.8% of the total. Reporting peaked in 2022 at $48,768 and has fallen 79.7% since, to $9,882 in 2024. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $572.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$61K
- AstraZeneca$47K
- Melinta Therapeutics, LLC$31K
- Abbott$1K
- Nabriva Therapeutics, PLC$1K
- Quidel Corporation$600
- plus $1K from 7 others
Across 30 payments — averaging $6773.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$75K
- Memed US, Inc.$70K
- Bausch Health US, LLC$47K
- BD$10K
What the payments were for
- Consulting fees$19,84614%
- Speaking & faculty fees$97,37568%
- Travel & lodging$18,86113%
- Food & beverage$6,7605%
- Education$1160%
- Entertainment$1890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 91 | $61,318 |
| AstraZeneca(2 entities) | 72 | $47,068 |
| Melinta Therapeutics, LLC | 63 | $30,683 |
| Abbott | 1 | $1,125 |
| Nabriva Therapeutics, PLC | 2 | $1,102 |
| Quidel Corporation | 2 | $600 |
| Boston Scientific | 10 | $471 |
| Memed US, Inc. | 3 | $417 |
| Kyowa Kirin, Inc. | 1 | $140 |
| Medtronic | 1 | $136 |
| Pfizer | 2 | $63 |
| AbbVie | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$143,146 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other emergency medicine in Houston
- William PeacockHouston$513K
- Basil KhalafHouston$93K
- Yen-Te TuHouston$60K
- Zubaid RafiqueHouston$52K
- Kelly LarkinHouston$48K
- Amanda HumphriesHouston$28K
- Bentley BobrowHouston$27K
- Samuel PraterHouston$22K
- Cedric DarkHouston$20K
- Amy WoehrmannHouston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.